Posted by
U.S. Food & Drug Administration Letter Regarding Mag Vita TMS Therapy System w/Theta Burst Stimulation

U.S. Food & Drug Administration Letter Regarding Mag Vita TMS Therapy System w/Theta Burst Stimulation

This Letter Shows that TBS is FDA Approved Tonica Elektronik A/S Sanne Jessen Medical Advisor Lucernemarken 15 Farum, 3520 Dk Re: K173620 Trade/Device Name: Mag Vita TMS Therapy System w/Theta Burst Stimulation Regulation Number: 21 CFR 882.5805 Regulation Name: Repetitive Transcranial Magnetic Stimulation System Regulatory Class: Class II Product Code: OBP Dated: July 10, 2018 […]

Posted by
Acetyl-l-carnitine deficiency in patients with major depressive disorder

Acetyl-l-carnitine deficiency in patients with major depressive disorder

Significance Identifying biological targets in major depressive disorder (MDD) is a critical step for development of effective mechanism-based medications. The epigenetic agent acetyl-L-carnitine (LAC) has rapid and enduring antidepressant-like effects in LAC-deficient rodents. Here, we found that LAC levels were decreased in patients with MDD versus age- and sex-matched healthy controls in two independent study […]

Posted by
Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States

Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States

June 12, 2018 Key Points Question  How frequently do US adults use prescription medications with depression as a potential adverse effect and is use of these medications associated with concurrent depression? Findings  In this cross-sectional US population-based survey study conducted between 2005 and 2014, the estimated overall prevalence of US adults using medications with depression as a potential adverse […]

Posted by
Magnetic Brain Stimulation Flops in VA Trial: Both sham and active rTMS produce high remission rates; unclear why

Magnetic Brain Stimulation Flops in VA Trial: Both sham and active rTMS produce high remission rates; unclear why

by Elizabeth Hlavinka, MedPage Today InternJune 27, 2018 About 40% of patients with treatment-resistant major depression achieved remission in a randomized trial of repetitive transcranial magnetic stimulation (rTMS) — but the rate was virtually the same with sham treatment versus active stimulation, researchers said. Among 81 patients in Veterans Affairs medical centers assigned to active rTMS, 33 […]

Posted by
The Benefits of TMS & TBS with MagVita

The Benefits of TMS & TBS with MagVita

TMS (Transcranial Magnetic Stimulation) is an FDA-cleared, non-invasive, non-drug therapy for patients with Major Depressive Disorders.  In our practice we use a highly advanced MagVita TMS therapy system that possesses unique attributes relative to other available products.  The market for TMS-based therapy has been growing, and the medical devices and accessories that are used to […]

Posted by

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial

Background Treatment-resistant major depressive disorder is common; repetitive transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side dorsolateral prefrontal cortex stimulation is an evidence-based treatment for this disorder. Intermittent theta burst stimulation (iTBS) is a newer form of rTMS that can be delivered in 3 min, versus 37·5 min for a standard 10 […]

Posted by
Ketamine: A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift

Ketamine: A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift

Ketamine, which has been called “the most important discovery in half a century,” just got a step closer to becoming the first new depression drug in 35 years. Johnson & Johnson, one of the pharmaceutical companies pursuing the drug’s fast-acting antidepressant qualities, presented some promising new research on Saturday that could raise the drug’s profile as a potential treatment for […]